[go: up one dir, main page]

MX2013006185A - Compuestos de 6-(piridinilmetoxi) -pirrolopiridina 3-sustituidos. - Google Patents

Compuestos de 6-(piridinilmetoxi) -pirrolopiridina 3-sustituidos.

Info

Publication number
MX2013006185A
MX2013006185A MX2013006185A MX2013006185A MX2013006185A MX 2013006185 A MX2013006185 A MX 2013006185A MX 2013006185 A MX2013006185 A MX 2013006185A MX 2013006185 A MX2013006185 A MX 2013006185A MX 2013006185 A MX2013006185 A MX 2013006185A
Authority
MX
Mexico
Prior art keywords
pyridinylmethoxy
substituted
formula
compounds
pyrrolopyridine compounds
Prior art date
Application number
MX2013006185A
Other languages
English (en)
Inventor
Magnus Wilhelm Walter
Carlos Lamas-Peteira
Simon James Richards
Selma Sapmaz
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2013006185A publication Critical patent/MX2013006185A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona ciertos compuestos de 6-(piridinilmetoxi)-pirrolopiridina 3-sustituidos, particularmente compuestos de fórmula I y composiciones farmacéuticas de los mismos. La invención además proporciona métodos para usar un compuesto de fórmula 1 para tratar la enfermedad de Parkinson.
MX2013006185A 2010-12-02 2011-11-17 Compuestos de 6-(piridinilmetoxi) -pirrolopiridina 3-sustituidos. MX2013006185A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382325 2010-12-02
US201161439438P 2011-02-04 2011-02-04
PCT/US2011/061212 WO2012074769A1 (en) 2010-12-02 2011-11-17 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds

Publications (1)

Publication Number Publication Date
MX2013006185A true MX2013006185A (es) 2013-07-15

Family

ID=45023893

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006185A MX2013006185A (es) 2010-12-02 2011-11-17 Compuestos de 6-(piridinilmetoxi) -pirrolopiridina 3-sustituidos.

Country Status (12)

Country Link
US (1) US8778946B2 (es)
EP (1) EP2646437B1 (es)
JP (1) JP5837938B2 (es)
KR (1) KR101547407B1 (es)
CN (1) CN103228656B (es)
AU (1) AU2011337041B2 (es)
BR (1) BR112013012494A2 (es)
CA (1) CA2819840C (es)
EA (1) EA021781B1 (es)
ES (1) ES2523282T3 (es)
MX (1) MX2013006185A (es)
WO (1) WO2012074769A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2509937A (en) 2013-01-17 2014-07-23 Nec Corp Providing security information to a mobile device in which user plane data and control plane signalling are communicated via different base stations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI954088A7 (fi) * 1993-03-01 1995-08-31 Merck Sharp & Dohme Pyrrolopyridiinijohdannaisia
US20050245540A1 (en) 2003-12-09 2005-11-03 Fujisawa Pharmaceutical Co., Ltd. New methods
WO2005056524A2 (en) * 2003-12-09 2005-06-23 Euro-Celtique S.A. Therapeutic agents useful for treating pain
KR100844864B1 (ko) 2004-02-27 2008-07-09 에프. 호프만-라 로슈 아게 헤테로아릴-융합 피라졸로 유도체
WO2006006610A1 (ja) * 2004-07-09 2006-01-19 Banyu Pharmaceutical Co., Ltd オキソピペラジン誘導体
JP5064219B2 (ja) 2005-07-22 2012-10-31 塩野義製薬株式会社 Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
MX2008010481A (es) * 2006-02-17 2008-12-19 Memory Pharm Corp Compuestos que tienen afinado para el receptor f-ht6.
US20090325964A1 (en) * 2008-05-23 2009-12-31 Wyeth Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
US8012992B2 (en) 2008-06-30 2011-09-06 Allergan, Inc. Aza-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2010124047A1 (en) * 2009-04-23 2010-10-28 Wyeth Llc Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)

Also Published As

Publication number Publication date
KR20130087027A (ko) 2013-08-05
BR112013012494A2 (pt) 2016-09-06
ES2523282T3 (es) 2014-11-24
WO2012074769A1 (en) 2012-06-07
US20130225602A1 (en) 2013-08-29
AU2011337041A1 (en) 2013-05-23
JP2013544836A (ja) 2013-12-19
EP2646437B1 (en) 2014-09-03
CA2819840A1 (en) 2012-06-07
KR101547407B1 (ko) 2015-08-25
EP2646437A1 (en) 2013-10-09
JP5837938B2 (ja) 2015-12-24
CA2819840C (en) 2015-05-26
CN103228656B (zh) 2015-09-30
EA201390619A1 (ru) 2013-11-29
CN103228656A (zh) 2013-07-31
EA021781B1 (ru) 2015-08-31
US8778946B2 (en) 2014-07-15
AU2011337041B2 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
MY153915A (en) Organic compounds
JOP20180103A1 (ar) مركب صيدلاني
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
UA110338C2 (xx) Хімічні сполуки
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
GEP20135964B (en) Inhibitors of beta-secretase
MD20150043A2 (ro) Inhibitori ai histon-demetilazelor
MX2011005934A (es) Compuestos organicos.
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
IN2015DN00960A (es)
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201300388A1 (ru) Соединения замещенного бензамида
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
GEP20156266B (en) Spiroheterocyclic n-oxypiperidines as pesticides
TN2014000095A1 (en) Pharmaceutical compositions
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
MX2012004780A (es) Inhibidores de akt.
MY187718A (en) Pharmaceutical formulations
MY160392A (en) Triptolide prodrugs
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201270728A1 (ru) Пуриновые соединения
MY180006A (en) Azetidinyloxyphenylpyrrolidine compounds

Legal Events

Date Code Title Description
FG Grant or registration